It is intended to provide a method of estimating a therapeutic effect of a physiologically active substance (in particular, an interferon) on cancer or a viral disease. This object is achieved by providing a method of estimating the effect of an interferon in treating cancer or a viral disease based on the expression dose of an interferon-associated gene in cancer or virus-infected cells.
